Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mast cell inhibition refers to the process of suppressing or modulating the activation and function of mast cells, which are immune cells involved in allergic reactions, inflammation, and host defense. Mast cell inhibition can be achieved by targeting specific receptors or signaling pathways that regulate mast cell degranulation and mediator release.
Suppression or modulation of mast cell activation and function by targeting receptors (FcεRI, KIT, Siglecs, CD200R, MRGPRX2) or signaling pathways (MAPK, Ca²⁺ influx, NF-κB) that regulate mast cell degranulation and mediator release.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mast Cell Inhibition.